Twist Bioscience
(NASDAQ) TWST
Twist Bioscience Financials at a Glance
Market Cap
$5.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$409.48M
Net Income (TTM)
-$81.28M
EPS (TTM)
-$1.33
P/E Ratio
-68.21
Dividend
$0.00
Beta (Volatility)
2.35 (High)
Dividend
$0.00
Beta (Volatility)
2.35 (High)
Price
$90.53
Volume
1,353,503.022
Open
$93.74
Price
$90.53
Volume
1,353,503.022
Open
$93.74
Previous Close
$90.64
Daily Range
$88.04 - $94.68
52-Week Range
$23.30 - $105.47
Estimated Earnings Date
Aug 3, 2026
Dividend
$0.00
Beta (Volatility)
2.35 (High)
Price
$90.53
Volume
1,353,503.022
Open
$93.74
Previous Close
$90.64
Daily Range
$88.04 - $94.68
52-Week Range
$23.30 - $105.47
Estimated Earnings Date
Aug 3, 2026
TWST News
TWST: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Twist Bioscience
Industry
Biotechnology
Sector
Health CareEmployees
979
CEO
Emily Marine Leproust, PhD
Website
www.twistbioscience.comHeadquarters
South San Francisco, CA 94080, US
TWST Financials
Key Financial Metrics (TTM)
Gross Margin
52.07%
Operating Margin
-33.90%
Net Income Margin
-19.85%
Return on Equity
-17.46%
Return on Capital
-22.33%
Return on Assets
-12.02%
Earnings Yield
-1.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
62.27M
Volume
1.35M
Avg. Volume
1.78M
Financials (TTM)
Gross Profit
$213.23M
Operating Income
-$138.82M
EBITDA
-$56.34M
Operating Cash Flow
-$55.59M
Capital Expenditure
-$39.55M
Free Cash Flow
-$95.14M
Cash & ST Invst.
$171.67M
Total Debt
$95.84M
Twist Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$110.72M
+19.3%
Gross Profit
$57.12M
+24.1%
Gross Margin
51.59%
N/A
Market Cap
$5.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$6.11M
N/A
Employees
923
N/A
Net Income
-$44.02M
-11.9%
EBITDA
-$37.78M
-15.9%
Quarterly Fundamentals
Total Cash
$171.67M
-33.2%
Total Debt
$95.84M
+19.4%
Accounts Receivable
$64.15M
+28.4%
Inventory
$33.52M
+60.7%
Long Term Debt
$85.40M
+31.2%
Short Term Debt
$10.44M
-31.4%
Return on Assets
-12.02%
N/A
Return on Invested Capital
-24.96%
N/A
Free Cash Flow
-$25.55M
-49.1%
Operating Cash Flow
-$17.56M
-35.2%